NCT00772265View on ClinicalTrials.gov

Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Diabetes
Interventions
BIOLOGICAL

Wosulin N

Total Dose per subject will be 0.4IU/Kg given Subcutaneously.

BIOLOGICAL

Novolin N

Total dose per subject will be 0.4 IU/Kg given Subcutaneously.

Trial Locations (1)

91911

Profil Institute for clinical Research, Chula Vista

Sponsors

Lead Sponsor

Wockhardt
All Listed Sponsors
lead

Wockhardt

INDUSTRY

NCT00772265 - Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects | Biotech Hunter | Biotech Hunter